Global Veterinary Vaccine Adjuvants 麻豆原创 Growth 2025-2031

Publication ID:

LPI03254018

Publication Date:

March 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Veterinary Vaccine Adjuvants market size is predicted to grow from US$ 358 million in 2025 to US$ 544 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
The 鈥淰eterinary Vaccine Adjuvants Industry Forecast鈥� looks at past sales and reviews total world Veterinary Vaccine Adjuvants sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccine Adjuvants sales for 2025 through 2031. With Veterinary Vaccine Adjuvants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccine Adjuvants industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Vaccine Adjuvants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Vaccine Adjuvants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Veterinary Vaccine Adjuvants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccine Adjuvants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccine Adjuvants.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Emulsion Adjuvants
Mineral Adjuvants
Others
Segmentation by Application:
Livestock Vaccines
Companion Animals Vaccines
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Vaccine Adjuvants market?
What factors are driving Veterinary Vaccine Adjuvants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Vaccine Adjuvants market opportunities vary by end market size?
How does Veterinary Vaccine Adjuvants break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Veterinary Vaccine Adjuvants Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Vaccine Adjuvants by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Vaccine Adjuvants by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Vaccine Adjuvants Segment by Type
2.2.1 Emulsion Adjuvants
2.2.2 Mineral Adjuvants
2.2.3 Others
2.3 Veterinary Vaccine Adjuvants Sales by Type
2.3.1 Global Veterinary Vaccine Adjuvants Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Veterinary Vaccine Adjuvants Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Veterinary Vaccine Adjuvants Sale Price by Type (2020-2025)
2.4 Veterinary Vaccine Adjuvants Segment by Application
2.4.1 Livestock Vaccines
2.4.2 Companion Animals Vaccines
2.5 Veterinary Vaccine Adjuvants Sales by Application
2.5.1 Global Veterinary Vaccine Adjuvants Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Veterinary Vaccine Adjuvants Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Veterinary Vaccine Adjuvants Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Veterinary Vaccine Adjuvants Breakdown Data by Company
3.1.1 Global Veterinary Vaccine Adjuvants Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Vaccine Adjuvants Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Veterinary Vaccine Adjuvants Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Vaccine Adjuvants Revenue by Company (2020-2025)
3.2.2 Global Veterinary Vaccine Adjuvants Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Veterinary Vaccine Adjuvants Sale Price by Company
3.4 Key Manufacturers Veterinary Vaccine Adjuvants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Vaccine Adjuvants Product Location Distribution
3.4.2 Players Veterinary Vaccine Adjuvants Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Veterinary Vaccine Adjuvants by Geographic Region
4.1 World Historic Veterinary Vaccine Adjuvants 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Vaccine Adjuvants Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Vaccine Adjuvants Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Vaccine Adjuvants 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Vaccine Adjuvants Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Vaccine Adjuvants Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Vaccine Adjuvants Sales Growth
4.4 APAC Veterinary Vaccine Adjuvants Sales Growth
4.5 Europe Veterinary Vaccine Adjuvants Sales Growth
4.6 Middle East & Africa Veterinary Vaccine Adjuvants Sales Growth
5 Americas
5.1 Americas Veterinary Vaccine Adjuvants Sales by Country
5.1.1 Americas Veterinary Vaccine Adjuvants Sales by Country (2020-2025)
5.1.2 Americas Veterinary Vaccine Adjuvants Revenue by Country (2020-2025)
5.2 Americas Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
5.3 Americas Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Vaccine Adjuvants Sales by Region
6.1.1 APAC Veterinary Vaccine Adjuvants Sales by Region (2020-2025)
6.1.2 APAC Veterinary Vaccine Adjuvants Revenue by Region (2020-2025)
6.2 APAC Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
6.3 APAC Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Vaccine Adjuvants by Country
7.1.1 Europe Veterinary Vaccine Adjuvants Sales by Country (2020-2025)
7.1.2 Europe Veterinary Vaccine Adjuvants Revenue by Country (2020-2025)
7.2 Europe Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
7.3 Europe Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Vaccine Adjuvants by Country
8.1.1 Middle East & Africa Veterinary Vaccine Adjuvants Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Vaccine Adjuvants Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Vaccine Adjuvants Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Vaccine Adjuvants Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine Adjuvants
10.3 Manufacturing Process Analysis of Veterinary Vaccine Adjuvants
10.4 Industry Chain Structure of Veterinary Vaccine Adjuvants
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Vaccine Adjuvants Distributors
11.3 Veterinary Vaccine Adjuvants Customer
12 World Forecast Review for Veterinary Vaccine Adjuvants by Geographic Region
12.1 Global Veterinary Vaccine Adjuvants 麻豆原创 Size Forecast by Region
12.1.1 Global Veterinary Vaccine Adjuvants Forecast by Region (2026-2031)
12.1.2 Global Veterinary Vaccine Adjuvants Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Vaccine Adjuvants Forecast by Type (2026-2031)
12.7 Global Veterinary Vaccine Adjuvants Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 SEPPIC
13.1.1 SEPPIC Company Information
13.1.2 SEPPIC Veterinary Vaccine Adjuvants Product Portfolios and Specifications
13.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 SEPPIC Main Business Overview
13.1.5 SEPPIC Latest Developments
13.2 SDA BIO
13.2.1 SDA BIO Company Information
13.2.2 SDA BIO Veterinary Vaccine Adjuvants Product Portfolios and Specifications
13.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 SDA BIO Main Business Overview
13.2.5 SDA BIO Latest Developments
13.3 Croda
13.3.1 Croda Company Information
13.3.2 Croda Veterinary Vaccine Adjuvants Product Portfolios and Specifications
13.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Croda Main Business Overview
13.3.5 Croda Latest Developments
13.4 SPI Pharma
13.4.1 SPI Pharma Company Information
13.4.2 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolios and Specifications
13.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SPI Pharma Main Business Overview
13.4.5 SPI Pharma Latest Developments
13.5 Phibro Animal Health
13.5.1 Phibro Animal Health Company Information
13.5.2 Phibro Animal Health Veterinary Vaccine Adjuvants Product Portfolios and Specifications
13.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Phibro Animal Health Main Business Overview
13.5.5 Phibro Animal Health Latest Developments
13.6 Vertellus
13.6.1 Vertellus Company Information
13.6.2 Vertellus Veterinary Vaccine Adjuvants Product Portfolios and Specifications
13.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Vertellus Main Business Overview
13.6.5 Vertellus Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.